What are the risks of investing in EYPT?
E
What are the risks of investing in EYPT?
🦉
EyePoint Pharmaceuticals, Inc. (EYPT)
Company Overview
Sector / IndustryHealthcare / Biotechnology
CEOJay S. Duker
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic...
Key Executives
| Name | Title |
|---|---|
| Anna Kluczewska | Chief Executive Officer of AION Diagnostics Ltd, President of AION Diagnostics Ltd and Director of AION Diagnostics Ltd |
| David Scott Jones | Senior Vice President |
| George O. Elston | Executive Vice President & Chief Financial Officer |
| Isabelle Lefebvre | Chief Regulatory Officer |
| Jay S. Duker | President, Chief Executive Officer & Director |
| Jennifer Leonard | Chief People Officer & Senior Vice President of IT |
Financial Health
Risk Assessment
Weather Score0/100
RegimeN/A